HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Giuliani Selected Research

Spinal Cord Injuries (Spinal Cord Injury)

1/2017Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela Giuliani Research Topics

Disease

12Ischemic Stroke
01/2017 - 03/2006
11Myocardial Ischemia (Ischemic Heart Diseases)
08/2023 - 08/2002
10Neoplasms (Cancer)
11/2023 - 11/2010
10Alzheimer Disease (Alzheimer's Disease)
10/2022 - 09/2013
10Shock
06/2012 - 01/2003
9Ischemia
12/2015 - 08/2002
9Brain Ischemia (Cerebral Ischemia)
05/2013 - 02/2004
5Stroke (Strokes)
11/2011 - 05/2006
3Cognitive Dysfunction
01/2022 - 10/2014
3Endometrial Neoplasms (Endometrial Cancer)
12/2017 - 01/2016
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 03/2014
3Infarction (Infarctions)
12/2015 - 07/2010
3Hypotension (Low Blood Pressure)
06/2012 - 01/2003
3Hemorrhagic Shock
03/2012 - 01/2003
3Reperfusion Injury
10/2011 - 11/2005
3Wounds and Injuries (Trauma)
04/2006 - 08/2002
2Neuroinflammatory Diseases
01/2024 - 01/2022
2Dementia (Dementias)
01/2022 - 03/2014
2Glioblastoma (Glioblastoma Multiforme)
06/2018 - 01/2018
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016 - 01/2016
2Inflammation (Inflammations)
03/2014 - 09/2013
2Traumatic Brain Injuries (Traumatic Brain Injury)
04/2012 - 03/2012
2Hemorrhage
03/2012 - 08/2004
2Necrosis
02/2011 - 07/2010
2Pain (Aches)
08/2004 - 07/2003
2Hypovolemia
08/2004 - 01/2003
1Teratoma (Teratoid Tumor)
01/2024
1Cardiovascular Diseases (Cardiovascular Disease)
12/2023
1Weight Loss (Weight Reduction)
11/2023
1Melanoma (Melanoma, Malignant)
11/2023
1Astrocytoma (Pilocytic Astrocytoma)
10/2022
1Amyloidosis
01/2022
1Ovarian Epithelial Carcinoma
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Memory Disorders (Memory Loss)
05/2017

Drug/Important Bio-Agent (IBA)

29MelanocortinsIBA
08/2023 - 08/2002
14Peptides (Polypeptides)IBA
10/2022 - 09/2003
12Melanocyte-Stimulating Hormones (MSH)IBA
01/2022 - 09/2003
8Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
11/2023 - 03/2006
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2013 - 01/2003
7Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2015 - 11/2005
7Adrenocorticotropic Hormone (ACTH)FDA Link
06/2013 - 08/2002
5Phosphotransferases (Kinase)IBA
09/2013 - 07/2010
5alpha-MSHIBA
07/2010 - 03/2006
4Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2013
4Caspase 3 (Caspase-3)IBA
09/2013 - 07/2010
4Neuroprotective AgentsIBA
03/2012 - 03/2006
4Cholinergic Agents (Cholinergics)IBA
10/2011 - 11/2005
4Messenger RNA (mRNA)IBA
02/2011 - 01/2003
3Melanocortin Receptors (Melanocortin Receptor)IBA
01/2022 - 09/2003
3Coloring Agents (Dyes)IBA
01/2017 - 01/2016
3Interleukin-10 (Interleukin 10)IBA
12/2014 - 02/2011
3salicylhydroxamic acid (SHAM)IBA
02/2011 - 01/2003
34-Nle-7-Phe-alpha- MSHIBA
07/2010 - 03/2009
3NF-kappa B (NF-kB)IBA
05/2006 - 01/2003
2LipidsIBA
01/2024 - 03/2009
22- (2- (2- (5- bromo- 2- methoxyphenyl)ethyl)- 3- fluorophenyl)- 4,5- dihydro- 1H- imidazoleIBA
11/2023 - 06/2018
2CholesterolIBA
10/2022 - 03/2009
2Biomarkers (Surrogate Marker)IBA
01/2020 - 03/2014
2Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2019 - 09/2013
2tau Proteins (tau Protein)IBA
05/2017 - 09/2013
2Amyloid (Amyloid Fibrils)IBA
05/2017 - 03/2014
2Janus KinasesIBA
12/2015 - 12/2014
2Interleukin-6 (Interleukin 6)IBA
12/2014 - 03/2012
2Epinephrine (Adrenaline)FDA LinkGeneric
12/2014 - 06/2012
2EnzymesIBA
06/2013 - 04/2006
2Cosyntropin (Cortrosyn)FDA LinkGeneric
06/2013 - 09/2003
2Bromodeoxyuridine (BrdU)IBA
05/2013 - 10/2011
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2012 - 04/2006
2Chlorisondamine (Chlorisondamine Chloride)IBA
05/2011 - 02/2011
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
05/2011 - 02/2011
2NeuropeptidesIBA
01/2010 - 05/2006
2Endothelin-1 (Endothelin 1)IBA
03/2009 - 09/2007
2NF-KappaB Inhibitor alphaIBA
05/2006 - 01/2003
2Free RadicalsIBA
11/2005 - 09/2003
2Hormones (Hormone)IBA
11/2005 - 09/2003
1SubtilisinIBA
12/2023
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
12/2023
1VemurafenibIBA
11/2023
1Amyloid beta-PeptidesIBA
10/2022
1Thyroid HormonesIBA
12/2021
1Amyloidogenic ProteinsIBA
01/2020
1Therapeutic UsesIBA
01/2020
1Temozolomide (Temodar)FDA LinkGeneric
06/2018
1Tetrachloroethylene (Tetrachloroethene)IBA
04/2018
1Trichloroethylene (Trichloroethene)IBA
04/2018
1Benzene (Benzole)IBA
04/2018
1Styrene (Styrol)IBA
04/2018
1EicosanoidsIBA
05/2017

Therapy/Procedure

5Ligation
12/2015 - 08/2002
3Drug Therapy (Chemotherapy)
01/2024 - 01/2018
3Lymph Node Excision (Lymph Node Dissection)
01/2021 - 11/2010
3Treatment Delay
08/2009 - 03/2006
2Therapeutics
11/2023 - 01/2022
2Heart Transplantation (Grafting, Heart)
04/2012 - 01/2010
2Intraperitoneal Injections
05/2011 - 02/2011
1Adjuvant Chemotherapy
01/2024
1Length of Stay
01/2018
1Radiotherapy
01/2018